| Literature DB >> 33133186 |
Wen-Li Lu1, Po-Chih Shen2,3, Chen-Hao Lee4,5, Yu-Tsun Su4,5, Li-Min Chen4,5.
Abstract
BACKGROUND: Chronic hyperglycemia in type 1 diabetes (T1D) patients results in ocular problems over time, but only a few studies emphasized on cataracts. AIM: To evaluate the epidemiology of cataracts in the T1D population.Entities:
Year: 2020 PMID: 33133186 PMCID: PMC7568800 DOI: 10.1155/2020/8160256
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Figure 1Study flow chart. Between 1998 and 2007, 5,893 patients were identified with new-onset type 1 diabetes (T1D) in Taiwan. After excluding 301 of those with pre-T1D cataracts and 1,970 of which computed tomography (CT) imaging studies were performed prior to being diagnosed with cataracts, a total of 3,622 cases were included. Equal numbers of age- and gender-matched individuals were selected from the Longitudinal Health Insurance Database (LHID) for analysis.
The demographic features of the type 1 diabetes (T1D) group and the matched group selected from the Longitudinal Health Insurance Database (LHID). The distribution of age and gender was similar between the two groups.
| T1D | LHID |
| |
|---|---|---|---|
| Age, yrs (mean ± SD) | 20.33 ± 13.86 | 20.74 ± 14.21 | 0.214 |
| <10(%) | 918 (25.4) | 918 (25.4) | 1.000 |
| 10–19(%) | 1169 (32.3) | 1169 (32.3) | |
| 20–29(%) | 717 (19.8) | 717 (19.8) | |
| 30–39(%) | 476 (13.1) | 476 (13.1) | |
| 40–49(%) | 220 (6.1) | 220 (6.1) | |
| 50–59(%) | 74 (2.0) | 74 (2.0) | |
| 60+(%) | 48 (1.3) | 48 (1.3) | |
| Male(%) | 1752 (48.4) | 1752 (48.4) | 1.000 |
| Steroid use(%) | 770 (21.3) | 1035 (28.6) | <0.001 |
| Total | 3622 | 3622 |
The hazard ratio (HR) of cataracts between the type 1 diabetes (T1D) group and the Longitudinal Health Insurance Database (LHID) group stratified by age of enrollment and gender. The younger T1D group had a higher HR of cataracts.
| T1D ( | LHID ( | Crude HR (95% CI) | |||
|---|---|---|---|---|---|
| Cataract no(%) | Time to cataract, mo±SD | Cataract no(%) | Time to cataract, mo±SD | ||
| Follow-up (mo) | 120.20 ± 42.22 | 133.02 ± 35.60 | |||
| Age of enrollment (yrs) | |||||
| <10 | 17 (0.5) | 73.51 ± 38.48 | 0 (0.0) | N/A | N/A |
| 10–19 | 101 (2.8) | 62.96 ± 47.12 | 0 (0.0) | N/A | N/A |
| 20–29 | 101 (2.8) | 52.36 ± 40.41 | 1 (0.02) | 124.83 ± 0.00 | 112.6 (15.72, 807.2) |
| 30–39 | 94 (2.60) | 64.62 ± 47.38 | 8 (0.2) | 119.26 ± 58.73 | 13.75 (6.68, 28.31) |
| 40–49 | 69 (1.91) | 61.29 ± 39.43 | 14 (0.4) | 78.25 ± 45.89 | 6.10 (3.43, 10.85) |
| 50–59 | 40 (1.10) | 51.05 ± 34.85 | 29 (0.8) | 77.62 ± 43.55 | 1.79 (1.11, 2,89) |
| 60+ | 25 (0.69) | 22.01 ± 25.34 | 32 (0.9) | 44.34 ± 43.72 | 0.86 (0.51, 1.45) |
| Gender | |||||
| Male | 176 (4.9) | 56.49 ± 39.24 | 36 (1.0) | 56.03 ± 38.28 | 5.20 (3.64, 7.45) |
| Female | 272 (7.5) | 58.47 ± 45.74 | 48 (1.3) | 79.74 ± 51.62 | 6.29 (4.63, 8.55) |
| Total | 448 (12.4) | 57.69 ± 43.27 | 84 (2.3) | 69.58 ± 47.61 | 5.81 (4.60, 7.33) |
p < 0.001.
Figure 2The cumulative incidence of cataracts in the type 1 diabetes group vs. the Longitudinal Health Insurance Database (LHID) group.
Figure 3Age of cataracts onset in the type 1 diabetes (T1D) group vs. the Longitudinal Health Insurance Database (LHID) group.
The demographic features of type 1 diabetes (T1D) patients newly registered during 1998–2013.
| Age of diabetes onset (yrs) |
|
|---|---|
| Mean ± SD | 22.99 ± 14.75 |
| <10 | 1769 (19.6) |
| 10–19 | 2754 (30.5) |
| 20–29 | 1859 (20.6) |
| 30–39 | 1432 (15.8) |
| 40–49 | 772 (8.6) |
| 50–59 | 281 (3.1) |
| 60+ | 172 (1.9) |
| Male | 4367 (48.4) |
| Total | 9032 |
The distribution of associated factors according the presence of cataracts.
| Cataract |
| ||
|---|---|---|---|
| Absent ( | Present ( | ||
| Male | 4030 (49.1) | 337 (41.1) | <0.001 |
| Retinopathy | 1021 (12.4) | 314 (38.3) | <0.001 |
| Amputation | 44 (0.5) | 12 (1.5) | 0.001 |
| ESRD | 136 (1.7) | 61 (7.4) | <0.001 |
| Steroid | 1926 (23.5) | 98 (12.0) | <0.001 |
ESRD, end-stage renal disease.
Figure 4The cumulative incidence of cataracts in the type 1 diabetes group divided by gender.